Frequencies for first 10,000 rows of indi_pt variable in indi2004q3 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABDOMINAL DISCOMFORT | 1 0.01 0.01 ABDOMINAL INFECTION | 2 0.02 0.03 ABDOMINAL PAIN | 8 0.08 0.11 ABDOMINAL PAIN UPPER | 6 0.06 0.17 ABDOMINAL SEPSIS | 2 0.02 0.19 ABNORMAL BEHAVIOUR | 6 0.06 0.25 ABNORMAL FAECES | 1 0.01 0.26 ABORTION INDUCED | 1 0.01 0.27 ABSCESS BACTERIAL | 1 0.01 0.28 ACARODERMATITIS | 7 0.07 0.35 ACCIDENTAL EXPOSURE | 1 0.01 0.36 ACNE | 22 0.22 0.58 ACNE CYSTIC | 1 0.01 0.59 ACQUIRED HAEMOPHILIA WITH ANTI FVIII,.. | 1 0.01 0.60 ACQUIRED IMMUNODEFICIENCY SYNDROME | 10 0.10 0.70 ACQUIRED PYLORIC STENOSIS | 1 0.01 0.71 ACROMEGALY | 6 0.06 0.77 ACTINIC KERATOSIS | 3 0.03 0.80 ACUTE CORONARY SYNDROME | 3 0.03 0.83 ACUTE LYMPHOCYTIC LEUKAEMIA | 6 0.06 0.89 ACUTE MYELOID LEUKAEMIA | 43 0.43 1.32 ACUTE MYOCARDIAL INFARCTION | 13 0.13 1.45 ACUTE PROMYELOCYTIC LEUKAEMIA | 6 0.06 1.51 ACUTE PSYCHOSIS | 1 0.01 1.52 ACUTE STRESS DISORDER | 3 0.03 1.55 ACUTE TONSILLITIS | 2 0.02 1.57 ADENOCARCINOMA | 9 0.09 1.66 ADENOCARCINOMA OF THE CERVIX | 2 0.02 1.68 AFFECTIVE DISORDER | 5 0.05 1.73 AGE INDETERMINATE MYOCARDIAL INFARCTION | 1 0.01 1.74 AGGRESSION | 1 0.01 1.75 AGITATION | 14 0.14 1.89 ALCOHOLISM | 2 0.02 1.91 ALLOGENIC BONE MARROW TRANSPLANTATION.. | 1 0.01 1.92 ALOPECIA | 3 0.03 1.95 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECT.. | 2 0.02 1.97 AMENORRHOEA | 2 0.02 1.99 AMINO ACID METABOLISM DISORDER | 1 0.01 2.00 AMYOTROPHIC LATERAL SCLEROSIS | 1 0.01 2.01 ANAEMIA | 9 0.09 2.10 ANAEMIA HAEMOLYTIC AUTOIMMUNE | 2 0.02 2.12 ANAEMIA OF MALIGNANT DISEASE | 10 0.10 2.22 ANAESTHESIA | 39 0.39 2.61 ANAL CANCER | 1 0.01 2.62 ANALGESIC EFFECT | 11 0.11 2.73 ANALGESIC THERAPY | 2 0.02 2.75 ANDROGEN THERAPY | 1 0.01 2.76 ANGER | 2 0.02 2.78 ANGINA PECTORIS | 29 0.29 3.07 ANGINA UNSTABLE | 5 0.05 3.12 ANGIOGRAM | 1 0.01 3.13 ANGIOGRAM PULMONARY | 1 0.01 3.14 ANGIOGRAM RETINA | 5 0.05 3.19 ANKYLOSING SPONDYLITIS | 10 0.10 3.29 ANTI-INFECTIVE THERAPY | 1 0.01 3.30 ANTIBACTERIAL PROPHYLAXIS | 1 0.01 3.31 ANTICOAGULANT THERAPY | 20 0.20 3.51 ANTIDEPRESSANT THERAPY | 1 0.01 3.52 ANTIEMETIC SUPPORTIVE CARE | 3 0.03 3.55 ANTIFUNGAL PROPHYLAXIS | 2 0.02 3.57 ANTIINFLAMMATORY THERAPY | 4 0.04 3.61 ANTIPLATELET THERAPY | 5 0.05 3.66 ANTIPYRESIS | 2 0.02 3.68 ANTITUSSIVE THERAPY | 2 0.02 3.70 ANTIVIRAL PROPHYLAXIS | 7 0.07 3.77 ANXIETY | 47 0.47 4.24 ANXIETY DISORDER | 3 0.03 4.27 AORTIC STENOSIS | 1 0.01 4.28 AORTIC VALVE REPLACEMENT | 4 0.04 4.32 APLASTIC ANAEMIA | 9 0.09 4.41 ARRHYTHMIA | 7 0.07 4.48 ARRHYTHMIA PROPHYLAXIS | 1 0.01 4.49 ARTERIAL STENOSIS | 1 0.01 4.50 ARTERIAL STENOSIS LIMB | 1 0.01 4.51 ARTERIAL STENT INSERTION | 1 0.01 4.52 ARTERIAL THROMBOSIS | 1 0.01 4.53 ARTERIOGRAM CORONARY | 3 0.03 4.56 ARTERIOSCLEROSIS | 1 0.01 4.57 ARTERIOSPASM CORONARY | 1 0.01 4.58 ARTHRALGIA | 61 0.61 5.19 ARTHRITIS | 85 0.85 6.04 ARTHRITIS INFECTIVE | 3 0.03 6.07 ARTHROPATHY | 8 0.08 6.15 ARTHROPOD BITE | 1 0.01 6.16 ARTHROSCOPIC SURGERY | 1 0.01 6.17 ARTHROSCOPY | 2 0.02 6.19 ASPERGER'S DISORDER | 1 0.01 6.20 ASPERGILLOSIS | 5 0.05 6.25 ASSISTED FERTILISATION | 1 0.01 6.26 ASTHMA | 112 1.12 7.38 ATHEROSCLEROSIS | 3 0.03 7.41 ATRIAL FIBRILLATION | 73 0.73 8.14 ATRIAL FLUTTER | 6 0.06 8.20 ATRIAL TACHYCARDIA | 1 0.01 8.21 ATRIAL THROMBOSIS | 1 0.01 8.22 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 32 0.32 8.54 AUTONOMIC NERVOUS SYSTEM IMBALANCE | 1 0.01 8.55 B-CELL SMALL LYMPHOCYTIC LYMPHOMA | 5 0.05 8.60 BACK DISORDER | 3 0.03 8.63 BACK PAIN | 70 0.70 9.33 BACTERIA STOOL IDENTIFIED | 1 0.01 9.34 BACTERIAL INFECTION | 2 0.02 9.36 BENIGN PROSTATIC HYPERPLASIA | 20 0.20 9.56 BIPOLAR DISORDER | 58 0.58 10.14 BIPOLAR I DISORDER | 12 0.12 10.26 BIPOLAR II DISORDER | 2 0.02 10.28 BLADDER CANCER | 34 0.34 10.62 BLADDER DISORDER | 2 0.02 10.64 BLADDER NEOPLASM | 1 0.01 10.65 BLADDER PAIN | 1 0.01 10.66 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA | 6 0.06 10.72 BLASTOMYCOSIS | 1 0.01 10.73 BLEPHAROSPASM | 1 0.01 10.74 BLOOD CHOLESTEROL | 15 0.15 10.89 BLOOD CHOLESTEROL ABNORMAL | 2 0.02 10.91 BLOOD CHOLESTEROL DECREASED | 1 0.01 10.92 BLOOD CHOLESTEROL INCREASED | 375 3.75 14.67 BLOOD CREATININE INCREASED | 1 0.01 14.68 BLOOD CULTURE POSITIVE | 2 0.02 14.70 BLOOD DISORDER | 2 0.02 14.72 BLOOD GLUCOSE DECREASED | 2 0.02 14.74 BLOOD GROWTH HORMONE ABNORMAL | 1 0.01 14.75 BLOOD HOMOCYSTEINE INCREASED | 1 0.01 14.76 BLOOD IRON INCREASED | 5 0.05 14.81 BLOOD PHOSPHORUS INCREASED | 2 0.02 14.83 BLOOD PRESSURE | 14 0.14 14.97 BLOOD PRESSURE ABNORMAL | 2 0.02 14.99 BLOOD PRESSURE DECREASED | 1 0.01 15.00 BLOOD PRESSURE INCREASED | 11 0.11 15.11 BLOOD PROLACTIN | 1 0.01 15.12 BLOOD TESTOSTERONE DECREASED | 1 0.01 15.13 BLOOD TRIGLYCERIDES | 1 0.01 15.14 BLOOD TRIGLYCERIDES DECREASED | 1 0.01 15.15 BLOOD TRIGLYCERIDES INCREASED | 18 0.18 15.33 BLOOD URIC ACID INCREASED | 1 0.01 15.34 BODY HEIGHT BELOW NORMAL | 1 0.01 15.35 BODY TINEA | 1 0.01 15.36 BONE DISORDER | 2 0.02 15.38 BONE MARROW CONDITIONING REGIMEN | 12 0.12 15.50 BONE MARROW TRANSPLANT | 29 0.29 15.79 BONE PAIN | 5 0.05 15.84 BONE SARCOMA | 5 0.05 15.89 BORDERLINE PERSONALITY DISORDER | 3 0.03 15.92 BRAIN ABSCESS | 2 0.02 15.94 BRAIN NEOPLASM | 5 0.05 15.99 BRAIN NEOPLASM BENIGN | 1 0.01 16.00 BRAIN NEOPLASM MALIGNANT | 2 0.02 16.02 BRAIN OEDEMA | 1 0.01 16.03 BREAST CANCER | 112 1.12 17.15 BREAST CANCER FEMALE | 18 0.18 17.33 BREAST CANCER IN SITU | 1 0.01 17.34 BREAST CANCER METASTATIC | 35 0.35 17.69 BREAST CANCER RECURRENT | 2 0.02 17.71 BREAST CANCER STAGE II | 2 0.02 17.73 BREAST CANCER STAGE IV | 1 0.01 17.74 BRIEF PSYCHOTIC DISORDER, WITH POSTPA.. | 1 0.01 17.75 BRONCHIAL CARCINOMA | 3 0.03 17.78 BRONCHIAL INFECTION | 2 0.02 17.80 BRONCHITIS | 42 0.42 18.22 BRONCHITIS ACUTE | 7 0.07 18.29 BRONCHITIS CHRONIC | 8 0.08 18.37 BRONCHOPNEUMONIA | 2 0.02 18.39 BRONCHOPULMONARY ASPERGILLOSIS | 9 0.09 18.48 BRONCHOSPASM | 4 0.04 18.52 BULIMIA NERVOSA | 5 0.05 18.57 BURSITIS | 3 0.03 18.60 CACHEXIA | 4 0.04 18.64 CAESAREAN SECTION | 1 0.01 18.65 CANCER PAIN | 45 0.45 19.10 CANDIDIASIS | 4 0.04 19.14 CARCINOMA | 21 0.21 19.35 CARCINOMA IN SITU | 1 0.01 19.36 CARDIAC DISORDER | 8 0.08 19.44 CARDIAC FAILURE | 25 0.25 19.69 CARDIAC FAILURE CHRONIC | 5 0.05 19.74 CARDIAC FAILURE CONGESTIVE | 25 0.25 19.99 CARDIAC MURMUR | 2 0.02 20.01 CARDIAC VALVE DISEASE | 3 0.03 20.04 CARDIOMEGALY | 3 0.03 20.07 CARDIOMYOPATHY | 3 0.03 20.10 CARDIOVASCULAR DISORDER | 4 0.04 20.14 CATARACT OPERATION | 8 0.08 20.22 CATHETER SITE DISCHARGE | 1 0.01 20.23 CATHETER SITE INFECTION | 1 0.01 20.24 CATHETERISATION CARDIAC | 7 0.07 20.31 CELLULITIS | 7 0.07 20.38 CELLULITIS STAPHYLOCOCCAL | 1 0.01 20.39 CENTRAL NERVOUS SYSTEM NEOPLASM | 1 0.01 20.40 CENTRAL VENOUS CATHETERISATION | 1 0.01 20.41 CEREBELLAR INFARCTION | 1 0.01 20.42 CEREBRAL INFARCTION | 13 0.13 20.55 CEREBRAL ISCHAEMIA | 2 0.02 20.57 CEREBRAL PALSY | 1 0.01 20.58 CEREBRAL SARCOIDOSIS | 1 0.01 20.59 CEREBROVASCULAR ACCIDENT | 17 0.17 20.76 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 10 0.10 20.86 CEREBROVASCULAR DISORDER | 3 0.03 20.89 CERVICAL CYST | 1 0.01 20.90 CERVICITIS | 2 0.02 20.92 CERVIX CARCINOMA | 4 0.04 20.96 CERVIX CARCINOMA RECURRENT | 5 0.05 21.01 CHEMOTHERAPY | 72 0.72 21.73 CHEMOTHERAPY CARDIOTOXICITY ATTENUATION | 1 0.01 21.74 CHEMOTHERAPY NEUROTOXICITY ATTENUATION | 1 0.01 21.75 CHEST PAIN | 5 0.05 21.80 CHEST WALL PAIN | 2 0.02 21.82 CHOLANGITIS | 1 0.01 21.83 CHOLECYSTITIS | 1 0.01 21.84 CHOLELITHIASIS | 4 0.04 21.88 CHOLESTASIS | 1 0.01 21.89 CHOREOATHETOSIS | 1 0.01 21.90 CHORIOCARCINOMA | 1 0.01 21.91 CHOROIDAL NEOVASCULARISATION | 1 0.01 21.92 CHRONIC HEPATITIS | 1 0.01 21.93 CHRONIC INFLAMMATORY DEMYELINATING PO.. | 5 0.05 21.98 CHRONIC LYMPHOCYTIC LEUKAEMIA | 8 0.08 22.06 CHRONIC MYELOID LEUKAEMIA | 21 0.21 22.27 CHRONIC OBSTRUCTIVE AIRWAYS DISEASE | 28 0.28 22.55 CHRONIC RESPIRATORY FAILURE | 1 0.01 22.56 CHRONIC SINUSITIS | 6 0.06 22.62 CIRCULATING ANTICOAGULANT | 1 0.01 22.63 CLOSTRIDIAL INFECTION | 1 0.01 22.64 CLOSTRIDIUM COLITIS | 2 0.02 22.66 COAGULATION FACTOR VIII LEVEL ABNORMAL | 1 0.01 22.67 COAGULOPATHY | 3 0.03 22.70 COGNITIVE DISORDER | 3 0.03 22.73 COLITIS | 3 0.03 22.76 COLITIS ULCERATIVE | 11 0.11 22.87 COLON CANCER | 38 0.38 23.25 COLON CANCER METASTATIC | 4 0.04 23.29 COLONOSCOPY | 3 0.03 23.32 COLONY STIMULATING FACTOR PROPHYLAXIS | 1 0.01 23.33 COLORECTAL CANCER | 36 0.36 23.69 COLORECTAL CANCER METASTATIC | 34 0.34 24.03 COLORECTAL CANCER STAGE IV | 1 0.01 24.04 COMPRESSION FRACTURE | 1 0.01 24.05 COMPUTERISED TOMOGRAM | 5 0.05 24.10 COMPUTERISED TOMOGRAM ABDOMEN | 2 0.02 24.12 CONDITION AGGRAVATED | 2 0.02 24.14 CONGENITAL APLASTIC ANAEMIA | 2 0.02 24.16 CONSTIPATION | 33 0.33 24.49 CONSTIPATION PROPHYLAXIS | 4 0.04 24.53 CONTRACEPTION | 47 0.47 25.00 CONVULSION | 48 0.48 25.48 CONVULSION PROPHYLAXIS | 1 0.01 25.49 CORONARY ANGIOPLASTY | 2 0.02 25.51 CORONARY ARTERIAL STENT INSERTION | 4 0.04 25.55 CORONARY ARTERY DISEASE | 25 0.25 25.80 CORONARY ARTERY OCCLUSION | 1 0.01 25.81 CORONARY ARTERY SURGERY | 2 0.02 25.83 COUGH | 11 0.11 25.94 CRANIOTOMY | 2 0.02 25.96 CROHN'S DISEASE | 31 0.31 26.27 CRYPTOCOCCOSIS | 1 0.01 26.28 CYSTITIS | 4 0.04 26.32 CYSTITIS INTERSTITIAL | 3 0.03 26.35 CYTOMEGALOVIRUS CHORIORETINITIS | 1 0.01 26.36 CYTOMEGALOVIRUS INFECTION | 3 0.03 26.39 CYTOMEGALOVIRUS OESOPHAGITIS | 1 0.01 26.40 DECUBITUS ULCER | 1 0.01 26.41 DEEP VEIN THROMBOSIS | 17 0.17 26.58 DEEP VENOUS THROMBOSIS PROPHYLAXIS | 1 0.01 26.59 DEFICIENCY ANAEMIA | 1 0.01 26.60 DEHYDRATION | 2 0.02 26.62 DELIRIUM | 7 0.07 26.69 DELUSION | 1 0.01 26.70 DELUSIONAL DISORDER, PERSECUTORY TYPE | 1 0.01 26.71 DELUSIONAL DISORDER, UNSPECIFIED TYPE | 1 0.01 26.72 DEMENTIA | 14 0.14 26.86 DEMENTIA ALZHEIMER'S TYPE | 36 0.36 27.22 DEMYELINATING POLYNEUROPATHY | 2 0.02 27.24 DENTAL CARE | 1 0.01 27.25 DENTAL OPERATION | 1 0.01 27.26 DENTAL TREATMENT | 1 0.01 27.27 DEPRESSED MOOD | 1 0.01 27.28 DEPRESSION | 258 2.58 29.86 DERMATITIS | 1 0.01 29.87 DERMATITIS ALLERGIC | 1 0.01 29.88 DERMATITIS ATOPIC | 3 0.03 29.91 DERMATITIS CONTACT | 2 0.02 29.93 DERMATOMYOSITIS | 1 0.01 29.94 DERMATOSIS | 1 0.01 29.95 DIABETES MELLITUS | 140 1.40 31.35 DIABETES MELLITUS INSULIN-DEPENDENT | 19 0.19 31.54 DIABETES MELLITUS NON-INSULIN-DEPENDENT | 73 0.73 32.27 DIABETIC GASTROPARESIS | 1 0.01 32.28 DIABETIC NEPHROPATHY | 3 0.03 32.31 DIABETIC NEUROPATHY | 4 0.04 32.35 DIABETIC RETINOPATHY | 3 0.03 32.38 DIABETIC ULCER | 1 0.01 32.39 DIAGNOSTIC PROCEDURE | 6 0.06 32.45 DIALYSIS | 4 0.04 32.49 DIARRHOEA | 6 0.06 32.55 DIFFUSE LARGE B-CELL LYMPHOMA | 4 0.04 32.59 DISEASE RECURRENCE | 3 0.03 32.62 DISSEMINATED INTRAVASCULAR COAGULATION | 1 0.01 32.63 DISSEMINATED TUBERCULOSIS | 8 0.08 32.71 DIURETIC THERAPY | 5 0.05 32.76 DIVERTICULITIS | 1 0.01 32.77 DIZZINESS | 4 0.04 32.81 DRUG ABUSER | 1 0.01 32.82 DRUG DEPENDENCE | 8 0.08 32.90 DRUG ERUPTION | 1 0.01 32.91 DRUG EXPOSURE DURING PREGNANCY | 3 0.03 32.94 DRUG INEFFECTIVE | 1 0.01 32.95 DRUG THERAPY CHANGED | 1 0.01 32.96 DRUG USE FOR UNKNOWN INDICATION | 253 2.53 35.49 DRY MOUTH | 3 0.03 35.52 DUODENAL ULCER | 3 0.03 35.55 DUODENAL ULCER HAEMORRHAGE | 2 0.02 35.57 DYSKINESIA | 1 0.01 35.58 DYSLIPIDAEMIA | 25 0.25 35.83 DYSMENORRHOEA | 3 0.03 35.86 DYSPEPSIA | 11 0.11 35.97 DYSPHAGIA | 1 0.01 35.98 DYSPNOEA | 2 0.02 36.00 DYSTHYMIC DISORDER | 1 0.01 36.01 DYSTONIA | 1 0.01 36.02 DYSURIA | 1 0.01 36.03 EAR INFECTION | 7 0.07 36.10 EATING DISORDER | 1 0.01 36.11 ECHINOCOCCIASIS | 1 0.01 36.12 ECZEMA | 4 0.04 36.16 EMPHYSEMA | 1 0.01 36.17 ENDOCARDITIS | 5 0.05 36.22 ENDOCARDITIS CANDIDA | 1 0.01 36.23 ENDOCARDITIS STAPHYLOCOCCAL | 2 0.02 36.25 ENDOCRINE OPHTHALMOPATHY | 1 0.01 36.26 ENDOMETRIAL CANCER | 4 0.04 36.30 ENDOMETRIAL HYPERPLASIA | 1 0.01 36.31 ENDOMETRIAL SARCOMA | 1 0.01 36.32 ENDOMETRIOSIS | 5 0.05 36.37 ENDOSCOPY | 1 0.01 36.38 ENTEROBACTER TRACHEOBRONCHITIS | 1 0.01 36.39 EPIDIDYMITIS | 1 0.01 36.40 EPIDURAL ANAESTHESIA | 3 0.03 36.43 EPIGASTRIC DISCOMFORT | 1 0.01 36.44 EPILEPSY | 77 0.77 37.21 EPISTAXIS | 1 0.01 37.22 EPULIS | 1 0.01 37.23 ERECTILE DYSFUNCTION | 28 0.28 37.51 ERYSIPELAS | 6 0.06 37.57 ESSENTIAL HYPERTENSION | 25 0.25 37.82 ESSENTIAL THROMBOCYTHAEMIA | 4 0.04 37.86 EWING'S SARCOMA | 4 0.04 37.90 EX-SMOKER | 6 0.06 37.96 EXPOSURE TO COMMUNICABLE DISEASE | 1 0.01 37.97 EXTRASYSTOLES | 2 0.02 37.99 EYE DISORDER | 2 0.02 38.01 FABRY'S DISEASE | 14 0.14 38.15 FACIAL NERVE DISORDER | 1 0.01 38.16 FACIAL PAIN | 2 0.02 38.18 FACIAL PALSY | 2 0.02 38.20 FACTOR IX DEFICIENCY | 1 0.01 38.21 FACTOR VIII DEFICIENCY | 9 0.09 38.30 FATIGUE | 1 0.01 38.31 FIBRINOUS BRONCHITIS | 1 0.01 38.32 FIBROMYALGIA | 8 0.08 38.40 FLANK PAIN | 1 0.01 38.41 FLUID REPLACEMENT | 1 0.01 38.42 FLUID RETENTION | 7 0.07 38.49 FOLLICLE CENTRE LYMPHOMA, FOLLICULAR .. | 4 0.04 38.53 FRACTURE | 1 0.01 38.54 FUNGAEMIA | 1 0.01 38.55 FUNGAL INFECTION | 5 0.05 38.60 FUSARIUM INFECTION | 4 0.04 38.64 GALLBLADDER CANCER | 1 0.01 38.65 GASTRIC BYPASS | 1 0.01 38.66 GASTRIC CANCER | 12 0.12 38.78 GASTRIC DISORDER | 2 0.02 38.80 GASTRIC ULCER | 25 0.25 39.05 GASTRIC ULCER HAEMORRHAGE | 2 0.02 39.07 GASTRITIS | 33 0.33 39.40 GASTRITIS EROSIVE | 1 0.01 39.41 GASTROENTERITIS HELICOBACTER | 2 0.02 39.43 GASTROINTESTINAL DISORDER | 1 0.01 39.44 GASTROINTESTINAL HAEMORRHAGE | 2 0.02 39.46 GASTROINTESTINAL STROMAL TUMOUR | 8 0.08 39.54 GASTROINTESTINAL ULCER | 1 0.01 39.55 GASTROOESOPHAGEAL REFLUX DISEASE | 35 0.35 39.90 GAUCHER'S DISEASE | 2 0.02 39.92 GENERAL ANAESTHESIA | 6 0.06 39.98 GENERAL SYMPTOM | 2 0.02 40.00 GENERALISED ANXIETY DISORDER | 6 0.06 40.06 GENITAL CANDIDIASIS | 1 0.01 40.07 GERM CELL CANCER | 3 0.03 40.10 GESTATIONAL DIABETES | 1 0.01 40.11 GLAUCOMA | 15 0.15 40.26 GLIOBLASTOMA | 2 0.02 40.28 GLIOBLASTOMA MULTIFORME | 9 0.09 40.37 GLIOMA | 3 0.03 40.40 GLOMERULONEPHRITIS | 1 0.01 40.41 GLOMERULONEPHRITIS PROLIFERATIVE | 1 0.01 40.42 GLUCOSE TOLERANCE IMPAIRED | 1 0.01 40.43 GLYCOPEPTIDE ANTIBIOTIC RESISTANT ENT.. | 1 0.01 40.44 GOITRE | 2 0.02 40.46 GOUT | 16 0.16 40.62 GRAFT VERSUS HOST DISEASE | 5 0.05 40.67 GRAND MAL CONVULSION | 3 0.03 40.70 GROWTH HORMONE DEFICIENCY | 10 0.10 40.80 HAEMANGIOMA | 1 0.01 40.81 HAEMATOPOIETIC STEM CELL MOBILISATION | 10 0.10 40.91 HAEMORRHAGE | 2 0.02 40.93 HAEMORRHAGIC DIATHESIS | 3 0.03 40.96 HAEMORRHOID OPERATION | 1 0.01 40.97 HAIRY CELL LEUKAEMIA | 3 0.03 41.00 HALLUCINATION | 4 0.04 41.04 HALLUCINATION, AUDITORY | 1 0.01 41.05 HEADACHE | 24 0.24 41.29 HEART DISEASE CONGENITAL | 3 0.03 41.32 HEART RATE INCREASED | 2 0.02 41.34 HEART RATE IRREGULAR | 3 0.03 41.37 HEART TRANSPLANT | 6 0.06 41.43 HELICOBACTER INFECTION | 7 0.07 41.50 HEPATIC CANCER METASTATIC | 1 0.01 41.51 HEPATIC CIRRHOSIS | 3 0.03 41.54 HEPATIC FUNCTION ABNORMAL | 2 0.02 41.56 HEPATIC NEOPLASM MALIGNANT | 11 0.11 41.67 HEPATIC NEOPLASM MALIGNANT NON-RESECT.. | 3 0.03 41.70 HEPATIC STEATOSIS | 1 0.01 41.71 HEPATITIS | 9 0.09 41.80 HEPATITIS B | 7 0.07 41.87 HEPATITIS C | 96 0.96 42.83 HEPATITIS C VIRUS | 2 0.02 42.85 HEPATITIS CHRONIC ACTIVE | 1 0.01 42.86 HERPES VIRUS INFECTION | 6 0.06 42.92 HERPES ZOSTER | 62 0.62 43.54 HIATUS HERNIA | 1 0.01 43.55 HIGH DENSITY LIPOPROTEIN DECREASED | 1 0.01 43.56 HIGH DENSITY LIPOPROTEIN INCREASED | 2 0.02 43.58 HIP ARTHROPLASTY | 1 0.01 43.59 HIRSUTISM | 1 0.01 43.60 HISTIOCYTOSIS HAEMATOPHAGIC | 4 0.04 43.64 HIV INFECTION | 258 2.58 46.22 HIV TEST POSITIVE | 3 0.03 46.25 HODGKIN'S DISEASE | 4 0.04 46.29 HODGKIN'S DISEASE NODULAR SCLEROSIS S.. | 2 0.02 46.31 HODGKIN'S DISEASE STAGE III | 2 0.02 46.33 HORMONE REPLACEMENT THERAPY | 241 2.41 48.74 HOT FLUSH | 3 0.03 48.77 HUNTINGTON'S CHOREA | 1 0.01 48.78 HYPERCALCAEMIA | 1 0.01 48.79 HYPERCHLORHYDRIA | 1 0.01 48.80 HYPERCHOLESTEROLAEMIA | 182 1.82 50.62 HYPERGLYCAEMIA | 1 0.01 50.63 HYPERHOMOCYSTEINAEMIA | 2 0.02 50.65 HYPERKALAEMIA | 1 0.01 50.66 HYPERLIPIDAEMIA | 84 0.84 51.50 HYPERPARATHYROIDISM | 1 0.01 51.51 HYPERPARATHYROIDISM SECONDARY | 2 0.02 51.53 HYPERPHOSPHATAEMIA | 14 0.14 51.67 HYPERPROLACTINAEMIA | 1 0.01 51.68 HYPERSENSITIVITY | 23 0.23 51.91 HYPERTENSION | 416 4.16 56.07 HYPERTHERMIA MALIGNANT | 1 0.01 56.08 HYPERTHYROIDISM | 4 0.04 56.12 HYPERTONIA | 1 0.01 56.13 HYPERTRIGLYCERIDAEMIA | 1 0.01 56.14 HYPERURICAEMIA | 6 0.06 56.20 HYPOAESTHESIA | 2 0.02 56.22 HYPOALBUMINAEMIA | 1 0.01 56.23 HYPOCALCAEMIA | 2 0.02 56.25 HYPOGAMMAGLOBULINAEMIA | 1 0.01 56.26 HYPOGONADISM | 1 0.01 56.27 HYPOKALAEMIA | 2 0.02 56.29 HYPOMANIA | 2 0.02 56.31 HYPONATRAEMIA | 1 0.01 56.32 HYPOPITUITARISM | 7 0.07 56.39 HYPOTENSION | 4 0.04 56.43 HYPOTHALAMO-PITUITARY DISORDERS | 3 0.03 56.46 HYPOTHYROIDISM | 15 0.15 56.61 HYPOTONIA | 1 0.01 56.62 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 1 0.01 56.63 ILL-DEFINED DISORDER | 210 2.10 58.73 IMMUNE SYSTEM DISORDER | 1 0.01 58.74 IMMUNOSUPPRESSANT DRUG THERAPY | 3 0.03 58.77 IMMUNOSUPPRESSION | 22 0.22 58.99 IMPAIRED GASTRIC EMPTYING | 4 0.04 59.03 IMPLANT SITE INFECTION | 5 0.05 59.08 INCISIONAL DRAINAGE | 2 0.02 59.10 INDUCED LABOUR | 2 0.02 59.12 INDUCTION OF ANAESTHESIA | 6 0.06 59.18 INFECTION | 24 0.24 59.42 INFECTION PROPHYLAXIS | 20 0.20 59.62 INFERTILITY | 2 0.02 59.64 INFLAMMATION | 17 0.17 59.81 INFLUENZA | 5 0.05 59.86 INJURY | 1 0.01 59.87 INSOMNIA | 47 0.47 60.34 INSULIN-REQUIRING TYPE II DIABETES ME.. | 5 0.05 60.39 INTERMITTENT EXPLOSIVE DISORDER | 1 0.01 60.40 INTERSTITIAL LUNG DISEASE | 10 0.10 60.50 INTERVERTEBRAL DISC DEGENERATION | 2 0.02 60.52 INTERVERTEBRAL DISC DISORDER | 1 0.01 60.53 INTERVERTEBRAL DISC PROTRUSION | 2 0.02 60.55 INTERVERTEBRAL DISCITIS | 3 0.03 60.58 INTESTINAL ANASTOMOTIC LEAK | 1 0.01 60.59 INTESTINAL FISTULA INFECTION | 1 0.01 60.60 INTESTINAL HAEMORRHAGE | 1 0.01 60.61 INTRACRANIAL INJURY | 1 0.01 60.62 INTRAOCULAR PRESSURE INCREASED | 3 0.03 60.65 INTRAVENOUS CATHETER MANAGEMENT | 2 0.02 60.67 INVESTIGATION | 1 0.01 60.68 IRIDOCYCLITIS | 1 0.01 60.69 IRON DEFICIENCY | 1 0.01 60.70 IRON DEFICIENCY ANAEMIA | 2 0.02 60.72 IRON METABOLISM DISORDER | 1 0.01 60.73 IRRITABILITY | 1 0.01 60.74 IRRITABLE BOWEL SYNDROME | 17 0.17 60.91 ISCHAEMIC CARDIOMYOPATHY | 3 0.03 60.94 ISCHAEMIC HEART DISEASE PROPHYLAXIS | 1 0.01 60.95 ISCHAEMIC STROKE | 1 0.01 60.96 JOINT ARTHROPLASTY | 1 0.01 60.97 JOINT DESTRUCTION | 1 0.01 60.98 JOINT INJURY | 2 0.02 61.00 JOINT SWELLING | 1 0.01 61.01 JUVENILE ARTHRITIS | 17 0.17 61.18 KAPOSI'S SARCOMA CLASSICAL TYPE | 2 0.02 61.20 KERATOCONJUNCTIVITIS SICCA | 1 0.01 61.21 KNEE ARTHROPLASTY | 3 0.03 61.24 LARGE INTESTINAL ULCER | 1 0.01 61.25 LARYNGEAL CANCER | 10 0.10 61.35 LARYNGITIS | 1 0.01 61.36 LARYNGOPHARYNGITIS | 2 0.02 61.38 LEARNING DISABILITY | 1 0.01 61.39 LEIOMYOSARCOMA | 2 0.02 61.41 LEISHMANIASIS | 1 0.01 61.42 LENNOX-GASTAUT SYNDROME | 1 0.01 61.43 LEUKAEMIA | 2 0.02 61.45 LIBIDO DECREASED | 1 0.01 61.46 LICE INFESTATION | 2 0.02 61.48 LIGAMENT SPRAIN | 1 0.01 61.49 LIPID METABOLISM DISORDER | 1 0.01 61.50 LIPIDS ABNORMAL | 2 0.02 61.52 LIPIDS INCREASED | 7 0.07 61.59 LIVER SCAN | 1 0.01 61.60 LIVER TRANSPLANT | 23 0.23 61.83 LOCAL ANAESTHESIA | 7 0.07 61.90 LOCALISED INFECTION | 5 0.05 61.95 LOCALISED OSTEOARTHRITIS | 9 0.09 62.04 LOW DENSITY LIPOPROTEIN INCREASED | 4 0.04 62.08 LOWER RESPIRATORY TRACT INFECTION | 3 0.03 62.11 LUMBAR PUNCTURE HEADACHE | 2 0.02 62.13 LUMBAR SPINAL STENOSIS | 2 0.02 62.15 LUNG ADENOCARCINOMA | 9 0.09 62.24 LUNG ADENOCARCINOMA STAGE IV | 3 0.03 62.27 LUNG DISORDER | 1 0.01 62.28 LUNG INFECTION PSEUDOMONAL | 1 0.01 62.29 LUNG NEOPLASM MALIGNANT | 21 0.21 62.50 LUNG SQUAMOUS CELL CARCINOMA STAGE IV | 1 0.01 62.51 LUNG SQUAMOUS CELL CARCINOMA STAGE UN.. | 5 0.05 62.56 LUPUS NEPHRITIS | 3 0.03 62.59 LYME DISEASE | 4 0.04 62.63 LYMPH NODE TUBERCULOSIS | 8 0.08 62.71 LYMPHOCYTIC LYMPHOMA | 1 0.01 62.72 LYMPHOMA | 11 0.11 62.83 LYMPHOPROLIFERATIVE DISORDER | 2 0.02 62.85 MACULAR DEGENERATION | 7 0.07 62.92 MACULAR OEDEMA | 1 0.01 62.93 MAINTENANCE OF ANAESTHESIA | 2 0.02 62.95 MAJOR DEPRESSION | 20 0.20 63.15 MALAISE | 1 0.01 63.16 MALARIA PROPHYLAXIS | 5 0.05 63.21 MALE PATTERN BALDNESS | 1 0.01 63.22 MALIGNANT MEDIASTINAL NEOPLASM | 2 0.02 63.24 MALIGNANT MELANOMA | 7 0.07 63.31 MALNUTRITION | 1 0.01 63.32 MANIA | 4 0.04 63.36 MANTLE CELL LYMPHOMA | 67 0.67 64.03 MEDICAL DIET | 1 0.01 64.04 MELAENA | 1 0.01 64.05 MEMORY IMPAIRMENT | 1 0.01 64.06 MENINGITIS | 7 0.07 64.13 MENINGITIS STAPHYLOCOCCAL | 1 0.01 64.14 MENINGITIS TUBERCULOUS | 5 0.05 64.19 MENINGOCOCCAL SEPSIS | 1 0.01 64.20 MENISCUS LESION | 1 0.01 64.21 MENOPAUSAL DISORDER | 3 0.03 64.24 MENOPAUSAL SYMPTOMS | 22 0.22 64.46 MENOPAUSE | 7 0.07 64.53 MENORRHAGIA | 3 0.03 64.56 MENSTRUAL DISORDER | 3 0.03 64.59 MENSTRUATION IRREGULAR | 2 0.02 64.61 MENTAL DISORDER | 6 0.06 64.67 MENTAL DISORDER DUE TO A GENERAL MEDI.. | 2 0.02 64.69 MENTAL RETARDATION SEVERITY UNSPECIFIED | 2 0.02 64.71 MESOTHELIOMA | 9 0.09 64.80 METABOLIC DISORDER | 1 0.01 64.81 METABOLIC SYNDROME | 1 0.01 64.82 METASTASES TO BONE | 13 0.13 64.95 METASTASES TO CENTRAL NERVOUS SYSTEM | 1 0.01 64.96 METASTASES TO LIVER | 7 0.07 65.03 METASTASES TO LUNG | 3 0.03 65.06 METASTASES TO LYMPH NODES | 1 0.01 65.07 METASTASES TO MENINGES | 1 0.01 65.08 METASTASES TO PERITONEUM | 1 0.01 65.09 METASTATIC MALIGNANT MELANOMA | 5 0.05 65.14 METASTATIC NEOPLASM | 1 0.01 65.15 METASTATIC RENAL CELL CARCINOMA | 6 0.06 65.21 MICTURITION URGENCY | 1 0.01 65.22 MIGRAINE | 38 0.38 65.60 MIGRAINE PROPHYLAXIS | 3 0.03 65.63 MITRAL VALVE PROLAPSE | 1 0.01 65.64 MITRAL VALVE REPLACEMENT | 2 0.02 65.66 MIXED CONNECTIVE TISSUE DISEASE | 2 0.02 65.68 MIXED HYPERLIPIDAEMIA | 2 0.02 65.70 MONARTHRITIS | 5 0.05 65.75 MOOD SWINGS | 5 0.05 65.80 MUCOPOLYSACCHARIDOSIS IH | 1 0.01 65.81 MULTIPLE ALLERGIES | 2 0.02 65.83 MULTIPLE MYELOMA | 91 0.91 66.74 MULTIPLE SCLEROSIS | 346 3.46 70.20 MULTIPLE SCLEROSIS RELAPSE | 2 0.02 70.22 MUSCLE CRAMP | 2 0.02 70.24 MUSCLE RELAXANT THERAPY | 3 0.03 70.27 MUSCLE SPASMS | 7 0.07 70.34 MUSCLE SPASTICITY | 4 0.04 70.38 MUSCLE TWITCHING | 1 0.01 70.39 MUSCULOSKELETAL DISCOMFORT | 2 0.02 70.41 MUSCULOSKELETAL PAIN | 7 0.07 70.48 MUSCULOSKELETAL STIFFNESS | 1 0.01 70.49 MYALGIA | 4 0.04 70.53 MYASTHENIA GRAVIS | 3 0.03 70.56 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 2 0.02 70.58 MYELODYSPLASTIC SYNDROME | 14 0.14 70.72 MYELOFIBROSIS | 1 0.01 70.73 MYOCARDIAL INFARCTION | 37 0.37 71.10 MYOCARDIAL ISCHAEMIA | 16 0.16 71.26 MYOCLONIC EPILEPSY | 1 0.01 71.27 NAIL INFECTION | 1 0.01 71.28 NAIL TINEA | 20 0.20 71.48 NARCOLEPSY | 2 0.02 71.50 NASAL CONGESTION | 4 0.04 71.54 NASAL POLYPS | 2 0.02 71.56 NASOPHARYNGITIS | 28 0.28 71.84 NAUSEA | 14 0.14 71.98 NECK PAIN | 5 0.05 72.03 NECROTISING ENTEROCOLITIS NEONATAL | 1 0.01 72.04 NEONATAL RESPIRATORY DISTRESS SYNDROME | 2 0.02 72.06 NEOPLASM | 1 0.01 72.07 NEOPLASM MALIGNANT | 2 0.02 72.09 NEOPLASM PROGRESSION | 3 0.03 72.12 NEOPLASM PROPHYLAXIS | 1 0.01 72.13 NEOPLASM RECURRENCE | 4 0.04 72.17 NEPHRITIS | 17 0.17 72.34 NEPHROLITHIASIS | 1 0.01 72.35 NEPHROTIC SYNDROME | 4 0.04 72.39 NERVOUS SYSTEM DISORDER | 1 0.01 72.40 NEURALGIA | 6 0.06 72.46 NEURODERMATITIS | 2 0.02 72.48 NEUROMUSCULAR BLOCKADE | 2 0.02 72.50 NEUROPATHIC PAIN | 7 0.07 72.57 NEUROPATHY | 4 0.04 72.61 NEUROPATHY PERIPHERAL | 3 0.03 72.64 NEUROSIS | 1 0.01 72.65 NEUTROPENIA | 2 0.02 72.67 NICOTINE DEPENDENCE | 1 0.01 72.68 NOCTURIA | 1 0.01 72.69 NODAL ARRHYTHMIA | 1 0.01 72.70 NON-HODGKIN'S LYMPHOMA | 41 0.41 73.11 NON-SMALL CELL LUNG CANCER | 95 0.95 74.06 NON-SMALL CELL LUNG CANCER RECURRENT | 1 0.01 74.07 NON-SMALL CELL LUNG CANCER STAGE III | 1 0.01 74.08 NON-SMALL CELL LUNG CANCER STAGE IV | 5 0.05 74.13 NUCLEAR MAGNETIC RESONANCE IMAGING | 1 0.01 74.14 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 2 0.02 74.16 NUTRITIONAL SUPPORT | 2 0.02 74.18 NYSTAGMUS | 1 0.01 74.19 OBESITY | 17 0.17 74.36 OBSESSIVE-COMPULSIVE DISORDER | 4 0.04 74.40 OBSTRUCTIVE AIRWAYS DISORDER | 1 0.01 74.41 OEDEMA | 7 0.07 74.48 OEDEMA PERIPHERAL | 9 0.09 74.57 OESOPHAGEAL CANDIDIASIS | 3 0.03 74.60 OESOPHAGEAL CARCINOMA | 6 0.06 74.66 OESOPHAGEAL DISORDER | 1 0.01 74.67 OESOPHAGITIS | 4 0.04 74.71 OESTROGEN REPLACEMENT THERAPY | 1 0.01 74.72 OLIGURIA | 1 0.01 74.73 ONYCHOMYCOSIS | 18 0.18 74.91 OPPOSITIONAL DEFIANT DISORDER | 1 0.01 74.92 ORAL CONTRACEPTION | 6 0.06 74.98 ORGANIC ERECTILE DYSFUNCTION | 2 0.02 75.00 ORTHOSTATIC HYPOTENSION | 2 0.02 75.02 OSTEITIS | 3 0.03 75.05 OSTEOARTHRITIS | 72 0.72 75.77 OSTEOGENESIS IMPERFECTA | 3 0.03 75.80 OSTEOMYELITIS | 5 0.05 75.85 OSTEOPENIA | 4 0.04 75.89 OSTEOPOROSIS | 144 1.44 77.33 OSTEOPOROSIS POSTMENOPAUSAL | 4 0.04 77.37 OSTEOPOROSIS PROPHYLAXIS | 1 0.01 77.38 OSTEOPOROTIC FRACTURE | 1 0.01 77.39 OTITIS EXTERNA | 3 0.03 77.42 OTITIS MEDIA | 3 0.03 77.45 OVARIAN CANCER | 24 0.24 77.69 OVARIAN CYST | 1 0.01 77.70 OVARIAN EPITHELIAL CANCER | 2 0.02 77.72 OVARIAN NEOPLASM | 1 0.01 77.73 OVERDOSE | 5 0.05 77.78 PAIN | 247 2.47 80.25 PAIN IN EXTREMITY | 23 0.23 80.48 PAIN MANAGEMENT | 2 0.02 80.50 PALLIATIVE CARE | 1 0.01 80.51 PANCREATIC CARCINOMA | 33 0.33 80.84 PANCREATIC CARCINOMA METASTATIC | 7 0.07 80.91 PANCREATIC DISORDER | 1 0.01 80.92 PANCREATIC INSUFFICIENCY | 1 0.01 80.93 PANCREATITIS CHRONIC | 1 0.01 80.94 PANCYTOPENIA | 2 0.02 80.96 PANIC ATTACK | 4 0.04 81.00 PANIC DISORDER | 5 0.05 81.05 PANIC DISORDER WITH AGORAPHOBIA | 1 0.01 81.06 PARANEOPLASTIC SYNDROME | 4 0.04 81.10 PARENTERAL NUTRITION | 1 0.01 81.11 PARKINSON'S DISEASE | 44 0.44 81.55 PARKINSONISM | 7 0.07 81.62 PARTIAL SEIZURES | 6 0.06 81.68 PATENT DUCTUS ARTERIOSUS | 14 0.14 81.82 PATHOGEN RESISTANCE | 1 0.01 81.83 PEMPHIGUS | 2 0.02 81.85 PEPTIC ULCER | 1 0.01 81.86 PERIODONTAL OPERATION | 1 0.01 81.87 PERIODONTITIS | 1 0.01 81.88 PERIOSTITIS | 1 0.01 81.89 PERIPHERAL MOTOR NEUROPATHY | 1 0.01 81.90 PERIPHERAL VASCULAR DISORDER | 4 0.04 81.94 PERITONEAL CANDIDIASIS | 1 0.01 81.95 PERITONEAL CARCINOMA | 4 0.04 81.99 PERITONEAL DIALYSIS | 1 0.01 82.00 PERITONITIS | 1 0.01 82.01 PERONEAL NERVE PALSY | 1 0.01 82.02 PERSONALITY DISORDER | 3 0.03 82.05 PHANTOM PAIN | 2 0.02 82.07 PHARYNGITIS | 8 0.08 82.15 PHARYNGITIS STREPTOCOCCAL | 1 0.01 82.16 PHARYNGOLARYNGEAL PAIN | 2 0.02 82.18 PHLEBITIS | 4 0.04 82.22 PLASMACYTOMA | 7 0.07 82.29 PLEURAL EFFUSION | 3 0.03 82.32 PLEURAL MESOTHELIOMA | 2 0.02 82.34 PLEURECTOMY | 1 0.01 82.35 PLEURISY | 1 0.01 82.36 PNEUMONIA | 54 0.54 82.90 PNEUMONIA ASPIRATION | 4 0.04 82.94 PNEUMONIA BACTERIAL | 1 0.01 82.95 PNEUMONIA MYCOPLASMAL | 2 0.02 82.97 PNEUMONIA STAPHYLOCOCCAL | 3 0.03 83.00 POLLAKIURIA | 4 0.04 83.04 POLYARTERITIS NODOSA | 3 0.03 83.07 POLYARTHRITIS | 1 0.01 83.08 POLYCYSTIC OVARIES | 1 0.01 83.09 POLYMYALGIA RHEUMATICA | 4 0.04 83.13 POLYMYOSITIS | 2 0.02 83.15 POST COITAL CONTRACEPTION | 2 0.02 83.17 POST HERPETIC NEURALGIA | 2 0.02 83.19 POST PROCEDURAL COMPLICATION | 1 0.01 83.20 POST PROCEDURAL PAIN | 24 0.24 83.44 POST-TRAUMATIC STRESS DISORDER | 9 0.09 83.53 POSTNASAL DRIP | 1 0.01 83.54 POSTOPERATIVE ANALGESIA | 1 0.01 83.55 POSTOPERATIVE CARE | 2 0.02 83.57 POSTOPERATIVE FEVER | 5 0.05 83.62 POSTOPERATIVE INFECTION | 2 0.02 83.64 POSTPARTUM HAEMORRHAGE | 1 0.01 83.65 PRE-ECLAMPSIA | 3 0.03 83.68 PRE-EXISTING DISEASE | 1 0.01 83.69 PRECANCEROUS CELLS PRESENT | 1 0.01 83.70 PRECOCIOUS PUBERTY | 1 0.01 83.71 PREMATURE BABY | 1 0.01 83.72 PREMATURE LABOUR | 5 0.05 83.77 PREMEDICATION | 52 0.52 84.29 PREMENSTRUAL SYNDROME | 1 0.01 84.30 PREOPERATIVE CARE | 18 0.18 84.48 PRIMITIVE NEUROECTODERMAL TUMOUR | 1 0.01 84.49 PRINZMETAL ANGINA | 4 0.04 84.53 PROGRESSIVE MULTIPLE SCLEROSIS | 2 0.02 84.55 PROLACTINOMA | 1 0.01 84.56 PROPHYLAXIS | 87 0.87 85.43 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 5 0.05 85.48 PROPHYLAXIS AGAINST HIV INFECTION | 1 0.01 85.49 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 16 0.16 85.65 PROPHYLAXIS OF NAUSEA AND VOMITING | 4 0.04 85.69 PROSTATE CANCER | 48 0.48 86.17 PROSTATE CANCER METASTATIC | 6 0.06 86.23 PROSTATE CANCER STAGE II | 2 0.02 86.25 PROSTATIC DISORDER | 2 0.02 86.27 PROSTATITIS | 2 0.02 86.29 PROTEIN C DEFICIENCY | 1 0.01 86.30 PRURITUS | 7 0.07 86.37 PSEUDOMONAS INFECTION | 1 0.01 86.38 PSEUDOMYXOMA PERITONEI | 1 0.01 86.39 PSORIASIS | 31 0.31 86.70 PSORIATIC ARTHROPATHY | 16 0.16 86.86 PSYCHOMOTOR AGITATION | 1 0.01 86.87 PSYCHOMOTOR HYPERACTIVITY | 1 0.01 86.88 PSYCHOTIC DISORDER | 30 0.30 87.18 PULMONARY CONGESTION | 1 0.01 87.19 PULMONARY EMBOLISM | 10 0.10 87.29 PULMONARY HYPERTENSION | 35 0.35 87.64 PULMONARY MYCOSIS | 1 0.01 87.65 PULMONARY OEDEMA | 1 0.01 87.66 PULMONARY TUBERCULOSIS | 4 0.04 87.70 PULMONARY VASCULITIS | 1 0.01 87.71 PYELONEPHRITIS CHRONIC | 1 0.01 87.72 PYOTHORAX | 1 0.01 87.73 PYREXIA | 23 0.23 87.96 RADIOTHERAPY | 1 0.01 87.97 RASH | 9 0.09 88.06 RASH PRURITIC | 1 0.01 88.07 RAYNAUD'S PHENOMENON | 1 0.01 88.08 RECTAL CANCER | 11 0.11 88.19 REFLUX OESOPHAGITIS | 10 0.10 88.29 RENAL AND PANCREAS TRANSPLANT | 3 0.03 88.32 RENAL CELL CARCINOMA STAGE UNSPECIFIED | 6 0.06 88.38 RENAL FAILURE | 1 0.01 88.39 RENAL FAILURE CHRONIC | 6 0.06 88.45 RENAL PAIN | 2 0.02 88.47 RENAL TRANSPLANT | 66 0.66 89.13 RESPIRATION ABNORMAL | 1 0.01 89.14 RESPIRATORY DISORDER | 2 0.02 89.16 RESPIRATORY TRACT INFECTION | 4 0.04 89.20 RESPIRATORY TRACT INFECTION BACTERIAL | 1 0.01 89.21 RESTLESS LEGS SYNDROME | 5 0.05 89.26 RESTLESSNESS | 4 0.04 89.30 RETINAL VEIN OCCLUSION | 1 0.01 89.31 RHABDOMYOLYSIS | 1 0.01 89.32 RHEUMATOID ARTHRITIS | 383 3.83 93.15 RHINITIS | 1 0.01 93.16 RHINITIS ALLERGIC | 8 0.08 93.24 RHINITIS SEASONAL | 1 0.01 93.25 RIB FRACTURE | 2 0.02 93.27 SALIVARY HYPERSECRETION | 1 0.01 93.28 SARCOIDOSIS | 2 0.02 93.30 SARCOMA | 4 0.04 93.34 SCAN MYOCARDIAL PERFUSION | 2 0.02 93.36 SCAN PARATHYROID | 1 0.01 93.37 SCAN WITH CONTRAST | 2 0.02 93.39 SCARLET FEVER | 1 0.01 93.40 SCHIZOAFFECTIVE DISORDER | 12 0.12 93.52 SCHIZOPHRENIA | 90 0.90 94.42 SCHIZOPHRENIA, PARANOID TYPE | 10 0.10 94.52 SCIATICA | 4 0.04 94.56 SCLERODERMA | 2 0.02 94.58 SCLEROTHERAPY | 1 0.01 94.59 SEASONAL ALLERGY | 2 0.02 94.61 SEDATION | 13 0.13 94.74 SENILE DEMENTIA | 1 0.01 94.75 SEPSIS | 32 0.32 95.07 SEPTIC SHOCK | 1 0.01 95.08 SEXUAL DYSFUNCTION | 2 0.02 95.10 SINUS CANCER METASTATIC | 4 0.04 95.14 SINUS CONGESTION | 2 0.02 95.16 SINUS DISORDER | 3 0.03 95.19 SINUSITIS | 26 0.26 95.45 SINUSITIS ASPERGILLUS | 1 0.01 95.46 SINUSITIS BACTERIAL | 1 0.01 95.47 SJOGREN'S SYNDROME | 1 0.01 95.48 SKIN DISORDER | 2 0.02 95.50 SKIN INFECTION | 1 0.01 95.51 SKIN ULCER | 3 0.03 95.54 SKIN WRINKLING | 1 0.01 95.55 SLEEP DISORDER | 11 0.11 95.66 SLEEP DISORDER THERAPY | 1 0.01 95.67 SMALL CELL CARCINOMA | 3 0.03 95.70 SMALL CELL LUNG CANCER EXTENSIVE STAGE | 4 0.04 95.74 SMALL CELL LUNG CANCER METASTATIC | 4 0.04 95.78 SMALL CELL LUNG CANCER RECURRENT | 2 0.02 95.80 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 15 0.15 95.95 SMALL INTESTINE TRANSPLANT | 1 0.01 95.96 SMOKING CESSATION THERAPY | 14 0.14 96.10 SOCIAL PHOBIA | 1 0.01 96.11 SOMNOLENCE | 1 0.01 96.12 SPINAL ANAESTHESIA | 1 0.01 96.13 SPINAL COLUMN STENOSIS | 2 0.02 96.15 SPINAL DISORDER | 1 0.01 96.16 SPINAL FRACTURE | 3 0.03 96.19 SPINAL OSTEOARTHRITIS | 3 0.03 96.22 SPONDYLITIS | 4 0.04 96.26 SPONDYLOARTHROPATHY | 2 0.02 96.28 SPONDYLOSIS | 3 0.03 96.31 SQUAMOUS CELL CARCINOMA | 6 0.06 96.37 STAPHYLOCOCCAL ABSCESS | 1 0.01 96.38 STAPHYLOCOCCAL BACTERAEMIA | 2 0.02 96.40 STAPHYLOCOCCAL INFECTION | 16 0.16 96.56 STAPHYLOCOCCAL SEPSIS | 2 0.02 96.58 STEM CELL TRANSPLANT | 21 0.21 96.79 STENT PLACEMENT | 5 0.05 96.84 STENT REMOVAL | 1 0.01 96.85 STOMACH DISCOMFORT | 3 0.03 96.88 STOMATITIS | 1 0.01 96.89 STREPTOCOCCAL INFECTION | 2 0.02 96.91 STREPTOCOCCAL SEPSIS | 3 0.03 96.94 STRESS SYMPTOMS | 4 0.04 96.98 STRESS ULCER | 2 0.02 97.00 SUBARACHNOID HAEMORRHAGE | 4 0.04 97.04 SUICIDE ATTEMPT | 23 0.23 97.27 SUPERINFECTION | 4 0.04 97.31 SURGERY | 4 0.04 97.35 SUTURE INSERTION | 1 0.01 97.36 SWELLING | 5 0.05 97.41 SYNOVITIS | 2 0.02 97.43 SYSTEMIC ANTIVIRAL TREATMENT | 7 0.07 97.50 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME | 1 0.01 97.51 SYSTEMIC LUPUS ERYTHEMATOSUS | 10 0.10 97.61 SYSTEMIC MYCOSIS | 2 0.02 97.63 TACHYCARDIA | 1 0.01 97.64 TEETHING | 1 0.01 97.65 TEMPORAL ARTERITIS | 2 0.02 97.67 TEMPORAL LOBE EPILEPSY | 1 0.01 97.68 TEMPOROMANDIBULAR JOINT SYNDROME | 1 0.01 97.69 TENDONITIS | 4 0.04 97.73 THALASSAEMIA | 3 0.03 97.76 THERAPEUTIC PROCEDURE | 1 0.01 97.77 THERMAL BURN | 2 0.02 97.79 THINKING ABNORMAL | 2 0.02 97.81 THROMBOCYTHAEMIA | 5 0.05 97.86 THROMBOCYTOPENIA | 2 0.02 97.88 THROMBOCYTOPENIA NEONATAL | 1 0.01 97.89 THROMBOPHLEBITIS | 2 0.02 97.91 THROMBOSIS | 6 0.06 97.97 THROMBOSIS PROPHYLAXIS | 16 0.16 98.13 THROMBOTIC STROKE | 1 0.01 98.14 THYROID CANCER METASTATIC | 2 0.02 98.16 THYROID DISORDER | 10 0.10 98.26 THYROID GLAND CANCER | 1 0.01 98.27 THYROIDECTOMY | 2 0.02 98.29 TINEA INFECTION | 1 0.01 98.30 TINNITUS | 1 0.01 98.31 TOBACCO ABUSE | 2 0.02 98.33 TONGUE NEOPLASM MALIGNANT STAGE UNSPE.. | 1 0.01 98.34 TONSIL CANCER | 2 0.02 98.36 TONSILLITIS | 4 0.04 98.40 TOOTH ABSCESS | 1 0.01 98.41 TOOTH DISORDER | 3 0.03 98.44 TOOTH EXTRACTION | 1 0.01 98.45 TOOTHACHE | 2 0.02 98.47 TORTICOLLIS | 1 0.01 98.48 TORULOPSIS INFECTION | 2 0.02 98.50 TOURETTE'S DISORDER | 2 0.02 98.52 TRACHEITIS | 1 0.01 98.53 TRANSIENT ISCHAEMIC ATTACK | 2 0.02 98.55 TREMOR | 2 0.02 98.57 TRICHOMONIASIS | 1 0.01 98.58 TRIGEMINAL NEURALGIA | 5 0.05 98.63 TUBERCULIN TEST | 4 0.04 98.67 TUBERCULIN TEST POSITIVE | 1 0.01 98.68 TUBERCULOSIS | 5 0.05 98.73 TUBERCULOSIS PROPHYLAXIS | 1 0.01 98.74 TUBEROUS SCLEROSIS | 1 0.01 98.75 TUMOUR LYSIS SYNDROME | 3 0.03 98.78 TYPE IIA HYPERLIPIDAEMIA | 8 0.08 98.86 ULCER | 2 0.02 98.88 UNRELATED DONOR BONE MARROW TRANSPLAN.. | 4 0.04 98.92 UPPER RESPIRATORY TRACT INFECTION | 9 0.09 99.01 UPPER RESPIRATORY TRACT INFLAMMATION | 7 0.07 99.08 URAEMIC PRURITUS | 1 0.01 99.09 URINARY INCONTINENCE | 3 0.03 99.12 URINARY RETENTION | 3 0.03 99.15 URINARY TRACT DISORDER | 1 0.01 99.16 URINARY TRACT INFECTION | 22 0.22 99.38 URINE ANALYSIS | 1 0.01 99.39 URINE OUTPUT DECREASED | 1 0.01 99.40 UROGRAPHY | 1 0.01 99.41 URTICARIA | 1 0.01 99.42 URTICARIA CHRONIC | 1 0.01 99.43 UTERINE CANCER | 7 0.07 99.50 UTERINE CONTRACTIONS DURING PREGNANCY | 2 0.02 99.52 UVEITIS | 2 0.02 99.54 VAGINAL CANCER | 1 0.01 99.55 VARICELLA | 2 0.02 99.57 VARICES OESOPHAGEAL | 1 0.01 99.58 VASCULITIS | 3 0.03 99.61 VENOUS INSUFFICIENCY | 1 0.01 99.62 VENOUS THROMBOSIS LIMB | 1 0.01 99.63 VENTRICULAR EXTRASYSTOLES | 3 0.03 99.66 VENTRICULAR FIBRILLATION | 1 0.01 99.67 VENTRICULAR HYPERTROPHY | 3 0.03 99.70 VENTRICULAR TACHYCARDIA | 7 0.07 99.77 VIRAL INFECTION | 1 0.01 99.78 VITAMIN A DEFICIENCY | 1 0.01 99.79 VITAMIN SUPPLEMENTATION | 1 0.01 99.80 VOMITING | 6 0.06 99.86 VON WILLEBRAND'S DISEASE | 1 0.01 99.87 WEIGHT CONTROL | 5 0.05 99.92 WEIGHT DECREASED | 3 0.03 99.95 WOUND | 1 0.01 99.96 WOUND INFECTION | 2 0.02 99.98 WOUND INFECTION STAPHYLOCOCCAL | 1 0.01 99.99 WRIST FRACTURE | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015